Dr. Kyle Jensen

CEO and Co-Founder

Kyle received his PhD in Neuroscience from Albert Einstein College of Medicine, where he used electrophysiology to study synaptic transmission and neural plasticity in live brain slices. At Duke University he worked in a drug-discovery lab, helping develop new tools that could potentially treat epilepsy and autism via the modulation of specific neural circuits. After three years in industry as Chief Science Officer of ExstoBio, Kyle co-founded Verse Therapeutics - with the mission of harnessing the power of plants to modulate neurobiology - towards a healthier body and mind.